Susceptibility of anaerobic bacteria to beta-lactam antibiotics and beta-lactamase production

References

1. Appelbaum P. C., Chatterton S. A. 1978; Susceptibility of anaerobic bacteria to ten antimicrobial agents. Antimicrobial Agents and Chemotherapy 14:371–376
   [Google Scholar]
2. Bach V. T., Thadeppalli H. 1980; Susceptibility of anaerobic bacteria in vitro to 23 antimicrobial agents. Chemotherapy 26:344–352
   [Google Scholar]
3. Bawdon R. E., Rozmiej E., Palchaudhuri S., Krakowiak J. 1979; Variability in the susceptibility pattern of Bacteroides fragilis in four Detroit area hospitals. Antimicrobial Agents and Chemotherapy 16:664–666
   [Google Scholar]
4. Bodner S. J., Koenig M. G., Treanor L. L., Goodman J. S. 1972; Antibiotic susceptibility testing of Bacteroides. Antimicrobial Agents and Chemotherapy 2:57–60
   [Google Scholar]
5. Brown J. E., Del Bene V. E., Collins C. D. 1981; In vitro activity of N-formimidoyl-thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance. Antimicrobial Agents and Chemotherapy 19:248–252
   [Google Scholar]
6. Dubois J., Pechere J. C., Turgeon P. 1978; Activity of ten antimicrobial agents against anaerobic bacteria. Journal of Antimicrobial Chemotherapy 4:329–334
   [Google Scholar]
7. Finegold S. M. 1979; Anaerobic infections. Archives of Internal Medicine 129:144–145
   [Google Scholar]
8. Finegold S. M., Hewitt W. L. 1956; Antibiotic sensitivity pattern of Bacteroides species. In Antibiotics annual edited by Welch H., Marti-Ibanez F. Medical Encyclopedia, Inc; New York: pp 794–801
   [Google Scholar]
9. Gabay E. L., Sutter V. C., Finegold S. M. 1981; Beta-lactamase testing in Bacteroides. American Society for Microbiology Annual Meeting p 12
   [Google Scholar]
10. Gill V. J., Manning C. B., Ingalls C. M. 1981; Correlation of penicillin minimum inhibitory concentration and penicillin zone edge appearance with staphylococcal beta-lactamase production. Journal of Clinical Microbiology 14:437–440
    [Google Scholar]
11. Greenberg R. N., Scalcini M. C., Sanders C. V., Lewis A. C. 1979; Cefamandole therapy in anaerobic infections. Antimicrobial Agents and Chemotherapy 15:337–341
    [Google Scholar]
12. Ingham H. R., Selkon J. B., Codd A. A., Hale J. H. 1968; A study in vitro of the sensitivity to antibiotics of Bacteroides fragilis. Journal of Clinical Pathology 21:432–436
    [Google Scholar]
13. Jorgensen J. H., Crawford S. A., Alexander G. A. 1980; Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteria. Antimicrobial Agents and Chemotherapy 17:901–904
    [Google Scholar]
14. Marrie T. J., Haldane E. V., Swantee C. A., Kerr E. A. 1981; Susceptibility of anaerobic bacteria to nine antimicrobial agents and demonstration of decreased susceptibility of Clostridum perfringens to penicillin. Antimicrobial Agents and Chemotherapy 19:51–55
    [Google Scholar]
15. Martin W. J., Gardner M., Washington J. A. 1972; In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens. Antimicrobial Agents and Chemotherapy 1:148–158
    [Google Scholar]
16. Mitchell A. A. B. 1973; Incidence and isolation of Bacteroides species from clinical material and their sensitivity to antibiotics. Journal of Clinical Pathology 26:738–741
    [Google Scholar]
17. Monif G. R. G., Clark P. R., Shuster J. J., Baer H. 1978; Susceptibility of the anerobic bacteria, group D streptococci, Enterobacteriaceae, and Pseudomonas to semisynthetic pencillins: carbenicillin, piperacillin, and ticarcillin. Antimicrobial Agents and Chemotherapy 14:643–649
    [Google Scholar]
18. Nastro L. J., Finegold S. M. 1972; Bactericidal activity of five antimicrobial agents against Bacteroides fragilis. Journal of Infectious Diseases 126:104–107
    [Google Scholar]
19. Nord C. E., Dornbusch K., Olsson B. 1980; Studies on beta-lactamase in Bacteroides fragilis. Infection 8: (Suppl. 2) 167–170
    [Google Scholar]
20. Sanders C. V., Lewis A. C. 1980; Changing trends in the antimicrobial susceptibility pattern of anaerobic bacteria. In Anaerobic bacteria; selected topics edited by Lambe D. W., Genco R. J., Mayberry-Carson K. J. Plenum Press; New York: pp 61–68
    [Google Scholar]
21. Staneck J. L., Washington J. A. 1974; Antimicrobial susceptibilities of anaerobic bacteria: recent clinical isolates. Antimicrobial Agents and Chemotherapy 6:311–315
    [Google Scholar]
22. Sutter V. L., Finegold S. M. 1976; Susceptibility of anaerobic bacteria to 23 antimicrobial agents. Antimicrobial Agents and Chemotherapy 10:736–752
    [Google Scholar]
23. Sykes R. B., Matthew M. 1976; The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics. Journal of Antimicrobial Chemotherapy 2:115–157
    [Google Scholar]
24. Tally F. P., Jacobus N. V., Bartlett J. G., Gorbach S. L. 1975; In vitro activity of penicillins against anaerobes. Antimicrobial Agents and Chemotherapy 7:413–414
    [Google Scholar]
25. Tally F. P., Jacobus N. V., Gorbach S. L. 1980; In vitro activity of N-Formimidoyl Thienamycin (MK0787). Antimicrobial Agents and Chemotherapy 18:642–644
    [Google Scholar]
26. Thadepalli H., Gorbach S. L., Bartlett J. G. 1977; Apparent failure of chloramphenicol in the treatment of anaerobic infections. Current Therapeutic Research 22:421–426
    [Google Scholar]
27. Weinrich A. E., Del Bene V. E. 1976; Beta-lactamase activity in anaerobic bacteria. Antimicrobial Agents and Chemotherapy 10:106–111
    [Google Scholar]
28. Zabransky R. J., Johnston J. A., Hauser K. J. 1973; Bacteriostatic and bactericidal activities of various antibiotics against Bacteroides fragilis. Antimicrobial Agents and Chemotherapy 3:152–156
    [Google Scholar]